Newsletter | Rod Porter Consultancy

In view of the large amount of time taken in assembling these newsletter I have decided to stop their preparation thus the December 2014 letter is my last. However I am working on other ways of putting my current favourite papers on view please visit my blog page on my website. Also I am intermittently chirruping on my Twitter account being @Rodchem and @SocMedRes (the latter being the Society of Medicines Research account)

Please find here copies of the (approximately) bimonthly newsletter produced by Rod Porter Consultancy. Articles include the latest thinking on medicinal chemistry, developability, screening strategy, conference reports and items of interest from the web along with analysis and comment. The latest and final Newsletter is for December 2014 RodPorterConsultancy Newsletter Dec 2014

2 thoughts on “Newsletter”

Thank you for the newsletter great job

admin says:

September 5, 2014 at 10:33 am

Thanks for the comment glad you like it
Rod

Reply

Leave a Reply to Montel Cancel reply

Newsletter Archive

RodPorterConsultancy Newsletter Oct 2014 vol 5 no_5 Q2 Regulatory approvals, Patent cliff 2013, who holds what – NME’s, Oncology reasons for failure, PAINful screening, Intrinsic clearance not PPB, Ionisation state and drug discovery, HDAC imaging, Screening strategies, P450 design out, Thiophenes and toxicity, Enzyme mediated chlorination, Photoredox, Useful illustrations, LINCS

RodPorterConsultancy Newsletter July 2014 vol 5 no_4 Big Beasts of the Future, Academy of Sciences report, peptide therapeutics, In vitro toxicology, Aromaticity descriptors, Finding binding sites, Transporters, Disordered proteins, SF5 – good bad or ugly, CNS penetrant ALK inhibitors, Translating P-gp substrates, Synthesis of ArCF2X

RodPorterConsultancy Newsletter June 2014 vol 5 no_3 Next generation, Drug approvals, From boom to bust, Megamergers, early response genes, Sex equality, Metabolite exposure, Validity of efficiency metrics part II, pi-stacking, QED scores, predicting clearance, transport v. passive permeability, long acting injectables, PPI reviews, Don’t forget chemistry, CH activation , nickel Cell Press, Lists, Recon 2.

RodPorterConsultancy Newsletter Aprl 2014 vol 5 no 2 Content of the April 2014 vol 5 no 2 Rod Porter Consultancy Newsletter: Complete response letters, Compounds approvedby company, Models, Sydney Brenner, ProteomeXchange, Once weekly dosing, Kinases, Peptides, Unbound drug fraction, Intramolecular H-bonds, Chromones – drugs, Directed meta-substitution, Pd CH-activation, ToxTree, Nature advances reviews

Rod Porter Consultancy Newsletter March 2014 vol 5 no_1 (1): IPO’s, 2014 pipeline value, Detecting Concussion, ADME SARfari, EPO synthesis, Developability – toxcast, hepatotox and AO, Rings in drugs, CNS delivery, P-gp, ligand efficiency (again), druggable PPI’s, (Hetero)Arylmethylketone synthesis